Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02345629 · ClinicalTrials.gov registry record · NA
Cordotomy for Refractory Cancer Pain
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02345629: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT02345629 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02345629, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if a cordotomy reduces pain in patients with unmanageable cancer pain. A cordotomy is a procedure, guided by computed tomography (CT) scans, that is performed on the spinal cord and is designed to reduce pain transmission.
Interventions
- PROCEDURE Cordotomy
- BEHAVIORAL Pain/Symptom Questionnaire
- PROCEDURE Sharpness Sensory Testing
- PROCEDURE Heat Pain Sensory Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-03-10 |
| Est. Completion | 2020-02-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02345629
The ClinicalTrials.gov registry entry for NCT02345629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cordotomy is the first listed.
NCT02345629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02345629 about?
NCT02345629 is a clinical study titled "Cordotomy for Refractory Cancer Pain". The goal of this clinical research study is to learn if a cordotomy reduces pain in patients with unmanageable cancer pain. A cordotomy is a procedure, guided by computed tomography (CT) scans, that is performed on the spinal cord and is designed to reduce pain transmission.
What is the current status of trial NCT02345629?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-03-10. Estimated completion is 2020-02-25.
What interventions are being tested in trial NCT02345629?
The interventions under investigation include: Cordotomy (PROCEDURE), Pain/Symptom Questionnaire (BEHAVIORAL), Sharpness Sensory Testing (PROCEDURE), Heat Pain Sensory Testing (PROCEDURE).
Who is sponsoring clinical trial NCT02345629?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.